Probiotics for the treatment of vaginal bacteriosis

Comparision of bacterial vaginosis recurrence rate between oral versus vaginal probiotic prescription in non pregnant women within reproductive and complaint of vaginal discharge

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20190202042596N1

Enrollment

Registered

2020-02-03

Start date

2020-01-27

Completion date

Unknown

Last updated

2020-02-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bacterial Vaginosis. ??????? ??? ??? ? ????

Interventions

Intervention 1: Intervention group: In the first intervention group, administration of metronidazole 500 mg every 12 hours for up to seven days and then continued for two weeks with one vaginal probio

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Laboratory- confirmed bacterial vaginosis Not using natural probiotics

Exclusion criteria

Exclusion criteria: No informed consent Having used natural probiotics during the 2 last weeks

Design outcomes

Primary

Measure	Time frame
Bacterial vaginosis recurrence. Timepoint: before and one month after the treatment. Method of measurement: Nugent score.	—

Secondary

Measure	Time frame
Evaluation of colonization of lactobacilli, their retention in vagina and establishment of normal vaginal environments within one month interval after treatment. Timepoint: one month. Method of measurement: Nugent Criteria.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMahnaz Boroumand Rezazadeh

Mashhad University of Medical Sciences

boroumandrm@mums.ac.ir+98 51 3602 3459

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026